உலகளாவிய மெநிஂகககல் தடுப்பு மருந்துகள் சந்தை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from உலகளாவிய மெநிஂகககல் தடுப்பு மருந்துகள் சந்தை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In உலகளாவிய மெநிஂகககல் தடுப்பு மருந்துகள் சந்தை Today - Breaking & Trending Today

Meningococcal Vaccines Market Key Players, Size, Trends, Growth Opportunities, Analysis and Forecast To 2027


Meningococcal Vaccines Market Key Players, Size, Trends, Growth Opportunities, Analysis and Forecast To 2027
iCrowd Newswire
16 May 2021, 08:13 GMT+10
Global Meningococcal Vaccines Market was valued at 1,938 million in 2019 which is expected to reach USD 4,196 million by 2027 at CAGR 9.3%.
Meningitis is caused by various fungi, bacteria, and viruses. The bacterial form of meningitis is called as meningococcal meningitis which is caused by Neisseria meningitides (meningococcus) bacteria. Meningococcal meningitis disease is prevented by using meningococcal vaccines.
Get Free Sample Copy Of This Report @
Increase n number of reportable cases of individuals suffering from meningococcal meningitis in the Sub-Saharan African region is the key driving factor which is expected to boost the global meningococcal vaccines market growth. For instance, in 2018, according to World Economic Forum s report around 37.4 million tourist arrivals were recorded in Sub-Saharan ....

United States , Asia Pacific , Vishal Thakur , Research Support Specialist , Emergent Biosolutions Inc , Browse Full Research , Qualiket Research , Merck Co Inc , Market Research , Research Newswire , Serum Institute Of India Pvt , Pfizer Inc , See Campaign , World Economic Forum , Global Meningococcal Vaccines Market , Free Sample Copy Of This Report , Sub Saharan African , Know More About , Meningococcal Vaccines Market , North America , Latin America , Middle East , Serum Institute , Emergent Biosolutions , Meningococcal Vaccines , Full Research Report ,

Meningococcal Vaccine Market to Receive Impetus from Introduction of a Series of Broad-range, Low-co


Search jobs
Meningococcal Vaccine Market to Receive Impetus from Introduction of a Series of Broad-range, Low-cost Vaccines
Meningococcal meningitis is a rare but potentially devastating bacterial infection that targets the brain. Despite growing advances in medical care, the disease can kill the host within a relatively lesser timespan. One in 10 meningococcal meningitis patients die from the disease, and ~15% of the survivors suffer from deadly complications, which typically include brain damage, deafness, or/and amputation.
Partnerships between the private sector and public institutions have been the chief agenda of global public health initiatives. The last few years have witnessed an increase in several private-public partnerships specifically focusing on vaccine provision in developing countries. Partnerships like the International Coordinating Group on Vaccine Provision for Epidemic Meningitis Control (ICG) help magnify the vaccine outr ....

United Arab Emirates , Mato Grosso Do Sul , Digestive Health , Bone Joint Health , Lab Automation Market , Heart Health , National Immunization Program , Ezequiel Dias Foundation , Institutional Health Centres , Global Alliance For Vaccines , Paediatric Vaccine Market Segmentation By Technology , International Coordinating Group , Vaccine Provision , Epidemic Meningitis Control , Global Alliance , Novartis Vaccines , Menjugate Menc , National Immunization , Sample Report , Worldwide Adoption , Meningococcal Vaccination , Middle East , Future Market Insights , Global Meningococcal Vaccines Market , Market Share Recorded , Vaccine Market Segmentation By Technology ,